Skip to Main Content

Paper Details

Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer.
PLoS Pathog
0
2022
CD4-binding site, Env, Env trimer, HIV, HIV-1, HIV-1 Env, HIV-1 envelope glycoproteins, HIV-1 envelope glycoproteins (Env)-specific IgG+ B cells, HIV-1 viruses, IgG, N, V3, antibody lineages, bNAb, bNAb lineage, gp120, gp41, monoclonal, patient, receptor binding site
Author NameAffiliation
Celia C LaBrancheDuke University Medical Center
Hanneke SchuitemakerAmsterdam Infection & Immunity Institute, University of Amsterdam
David C MontefioriDuke University Medical Center
Michael S SeamanCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Ian A WilsonThe Scripps Research Institute
Ian A WilsonThe Scripps Research Institute
Ian A WilsonThe Scripps Research Institute
Ian A WilsonThe Skaggs Institute for Chemical Biology, The Scripps Research Institute
  • 1 - 8

Datasets

Release 1.2